22 November 2023 | News
Inks MoU with Kalbe Farma, the largest publicly-listed pharmaceutical company in Southeast Asia
Fapon, a global leading life sciences organisation, has unveiled its innovative integrated solutions for diagnostics and forged strategic partnerships at the 55th International Hospital and Medical Equipment Exhibition (MEDICA 2023), held from November 13th to 16th, 2023, at the Düsseldorf Convention and Exhibition Center in Germany. At MEDICA, Fapon presented the latest advancements in its open platform-based diagnostic ecosystem to the market.
At MEDICA, Zhiqiang HE, President of Fapon Biotech, and Vidjongtius, President Director of PT Kalbe Farma Tbk, signed a Memorandum of Understanding (MoU) to deepen cooperation and boost Indonesia's IVD development. Kalbe Farma, established in 1966, is the largest publicly-listed pharmaceutical company in Southeast Asia. It manages four business divisions: the prescription pharmaceutical division, consumer health, nutritional and distribution & logistics divisions, serving over one million outlets across Indonesia’s vast archipelago.
This collaboration marks another significant milestone for Fapon as it strengthens its presence in the Indonesian market, following a previous partnership forged in October of this year with Halodoc, the largest telehealth platform in Indonesia.